Reply to "Wild-type AAV insertions in hepatocellular carcinoma do not inform debate over genotoxicity risk of vectorized AAV"

Molecular Therapy

Volumn 24, Issue 4, 2016, Pages 661-662

  Schmidt, Manfred ^a   Gil Farina, Irene ^a   Büning, Hildegard ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; ADENOVIRUS VECTOR; TELOMERASE REVERSE TRANSCRIPTASE;

ADENO ASSOCIATED VIRUS 2; CARCINOGENESIS; GENOTOXICITY; HIGH THROUGHPUT SEQUENCING; HUMAN; LETTER; LIVER CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; RISK ASSESSMENT; VIRUS GENOME; VIRUS REPLICATION; WILD TYPE; DEPENDOPARVOVIRUS; GENE VECTOR; GENETICS; LIVER TUMOR; CHROMOSOME 19; CHRONIC HEPATITIS B; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; ONCOGENE; STRAIN DIFFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRUS CELL INTERACTION;

CARCINOMA, HEPATOCELLULAR; DEPENDOVIRUS; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS;

EID: 84964388816     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2016.48     Document Type: Letter

References (16)

1. Nault, J-C, Mami, I, La Bella, T, Datta, S, Imbeaud, S, Franconi, A, et al. (2016). AAV Insertions in hepatocellular carcinoma do not inform debate over genotoxicity risk of vectorized AAV. Mol Ther 24: 660-661
2. Büning, H, and Schmidt, M. (2015). Adeno-Associated vector toxicity-To be or not to be?. Mol Ther 23: 1673-1675
3. Nault, J-C, Datta, S, Imbeaud, S, Franconi, A, Mallet, M, Couchy, G, et al. (2015). Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 47: 1187-1193
4. Nault, JC, Mallet, M, Pilati, C, Calderaro, J, Bioulac-Sage, P, Laurent, C, et al. (2013). High frequency of telomerase reverse-Transcriptase promoter somatic mutations in hepatocellular carcinoma, and preneoplastic lesions. Nat Commun 4: 2218
5. Ward, P, and Walsh, CE. (2012). Targeted integration of a rAAV vector into the AAVS1 region. Virology 433: 356-366
6. Musayev, FN, Zarate-Perez, F, Bishop, C, Burgner, JW, and Escalante, CR. (2015). Structural insights into the assembly of the adeno-Associated virus type 2 Rep68 protein on the integration site AAVS1. J Biol Chem 290: 27487-27499
7. Meneses, P, Berns, KI, and Winocour, E. (2000). DNA sequence motifs which direct adeno-Associated virus site-specific integration in a model system. J Virol 74: 6213-6216
8. Rizzuto, G, Gorgoni, B, Cappelletti, M, Lazzaro, D, Gloaguen, I, Poli, V, et al. (1999). Development of animal models for adeno-Associated virus site-specific integration. J Virol 73: 2517-2526
9. Huang, S, Kawabe, Y, Ito, A, and Kamihira, M. (2012). Adeno-Associated virus Rep-mediated targeting of integrase-defective retroviral vector DNA circles into human chromosome 19. Biochem Biophys Res Commun 417: 78-83
10. Howden, SE, Voullaire, L, Wardan, H, Williamson, R, and Vadolas, J. (2008). Site-specific, Rep-mediated integration of the intact beta-globin locus in the human erythroleukaemic cell line K562. Gene Ther 15: 1372-1383
11. Cortés, ML, Oehmig, A, Saydam, O, Sanford, JD, Perry, KF, Fraefel, C, et al. (2008). Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector. Mol Ther 16: 81-88
12. Xu, ZX, Chen, JZ, Yue, YB, Zhang, JQ, Li, ZH, Feng, DM, et al. (2009). A 16-bp RBE element mediated Rep-dependent site-specific integration in AAVS1transgenic mice for expression of hFIX. Gene Ther 16: 589-595
13. Hüser, D, Gogol-Döring, A, Chen, W, and Heilbronn, R. (2014). Adeno-Associated virus type 2 wild-Type, and vector-mediated genomic integration profiles of human diploid fibroblasts analyzed by thirdgeneration PacBio DNA sequencing. J Virol 88: 11253-11263
14. Petri, K, Gabriel, R, Agundez, L, Fronza, R, Afzal, S, Kaeppel, C, et al. (2015). Presence of a trs-like motif promotes Rep-mediated wild-Type adeno-Associated virus type 2 integration. J Virol 89: 7428-7432
15. Chandler, RJ, LaFave, MC, Varshney, GK, Trivedi, NS, Carrillo-Carrasco, N, et al. (2015). Vector design influences hepatic genotoxicity after adeno-Associated virus gene therapy. J Clin Invest. 125: 870-880
16. Berns, KI, Byrne, BJ, Flotte, TR, Gao, G, Hauswirth, WW, Herzog, RW, et al. (2015). Adeno-Associated virus type 2, and hepatocellular carcinoma?. Hum Gene Ther 26: 779-781